Aurobindo Pharma has incorporated a wholly owned subsidiary, Engenra Biologics, to expand its contract manufacturing operations.
Besides contract manufacturing, the objective is also to expand other pharmaceutical manufacturing operations, Aurobindo Pharma said on Tuesday in a filing.
Published – February 24, 2026 11:44 pm IST
West Asia turmoil pushes OMC fuel losses to ₹530 crore a day. Crude oil prices…
Simple Energy unveils modes at Nandi Hills | Photo Credit: The Hindu Bengaluru-based electric vehicle…
Image used for representational purposes. File | Photo Credit: Reuters The government is in the…
Image for representational purposes only. | Photo Credit: The power ministry has accorded in-principle clearance…
Smartphone prices have gone up by up to ₹2,000 in India due to sustained price…
The Department of Economic Affairs report said that the Indian economy may experience “nervous but…
